1.46 XY Gonadal Dysgenesis mimicking Turner Syndrome: Diagnostic challenges and clinical implications
Suseelah Bala Subramaniam ; Rabeah Md Zuki ; Loh Hoong Heng
Journal of the ASEAN Federation of Endocrine Societies 2026;41(S1):13-
Introduction:
Swyer syndrome (46, XY gonadal dysgenesis) is a rare disorder of sex development, characterized by a phenotypic female
with streak gonads and hypergonadotropic hypogonadism. It presents with primary amenorrhea and delayed puberty.
Overlapping clinical features with Turner syndrome may cause diagnostic uncertainty, highlighting the role of karyotypic
evaluation in diagnosis.
Case:
A 35-year-old phenotypic female was first evaluated at age 27 during admission for an acute viral illness, when incidental
findings of primary amenorrhea, short stature (height 131 cm), webbed neck, pectus excavatum, and absent secondary
sexual characteristics raised suspicion of Turner syndrome. She had hypertension, with initial imaging suggesting
coarctation of the thoracic aorta. CT angiography showed focal narrowing of the descending aorta; multidisciplinary review
favored aortic folding, and she was managed conservatively. Endocrine evaluation demonstrated hypergonadotropic
hypogonadism, with markedly elevated follicle-stimulating hormone (FSH 108.6 IU/L) and luteinizing hormone (LH 23.16
IU/L) in the presence of low estradiol levels. Pelvic imaging revealed an atrophic uterus with absence of bilateral ovaries,
consistent with gonadal dysgenesis. Karyotypic analysis was performed, demonstrating a 46, XY genotype with confirmed
SRY gene presence, establishing the diagnosis of Swyer syndrome. DEXA scan demonstrated osteoporosis, in keeping
with prolonged hypogonadism. She was commenced on hormone replacement therapy, resulting in the development
of secondary sexual characteristics and regular withdrawal bleeding. She remains under structured multidisciplinary
follow-up, with endocrine-led management of hypothyroidism and osteoporosis, alongside cardiology follow-up and
gynecological surveillance.
Conclusion
This case highlights the diagnostic complexity of disorders of sex development with overlapping phenotypes and the need
for re-evaluation when clinical progression is atypical. Diagnosis enables hormone replacement therapy for induction of
secondary sexual characteristics and preservation of bone health. Integration of clinical, biochemical, and genetic data
within a multidisciplinary framework is essential to achieve diagnostic accuracy and optimize outcomes.
Turner Syndrome
2.Isolated Cranial Diabetes Insipidus Unmasked After Hyperosmolar Hyperglycemic State in Type 2 Diabetes Mellitus
Suseelah Bala Subramaniam ; Rabeah Md Zuki ; Loh Hoong Heng
Journal of the ASEAN Federation of Endocrine Societies 2026;41(S1):94-95
Introduction:
Central diabetes insipidus (CDI) is characterized by
impaired arginine vasopressin secretion, resulting in
hypotonic polyuria and hypernatremia. In patients with
coexisting diabetes mellitus, persistent polyuria may be
misattributed to hyperglycemia, delaying recognition
of a concurrent water balance disorder. CDI without
identifiable structural abnormalities may be overlooked,
leading to delayed diagnosis and complications.
Case:
We report a 30-year-old Malay female with underlying type
2 diabetes mellitus and premorbid obesity who presented
with hyperosmolar hyperglycemic state, accompanied
by persistent polyuria, polydipsia, weight gain, and
amenorrhea. Despite resolution of hyperglycemia, she had
ongoing polyuria with hypernatremia, raising suspicion
of a concomitant water balance disorder.
Biochemical evaluation demonstrated a hyperosmolar state
with serum osmolality 334 mOsm/kg and inappropriately
dilute urine (urine osmolality 254 mOsm/kg), supporting
impaired vasopressin activity. A modified water deprivation
test showed a >50% rise in urine osmolality following
desmopressin, consistent with CDI. Diabetes autoantibody
screening was negative. Anterior pituitary function was
preserved, with normal thyroid and adrenal axes (thyroidstimulating hormone 3.30 mIU/L, cortisol 290.6 nmol/L),
and gonadotropins not suggestive of hypopituitarism
(luteinizing hormone 6.8 IU/L, follicle-stimulating hormone
24.6 IU/L).
Neuroimaging with computed tomography brain showed
no structural hypothalamic–pituitary lesion. Magnetic
resonance imaging of the pituitary demonstrated absence
of the posterior pituitary bright spot, with preserved gland
morphology and no focal lesion, supporting CDI without
an identifiable structural cause. Her clinical course was complicated by severe hospitalacquired infection leading to septic shock, requiring
intensive care support, mechanical ventilation, and renal
replacement therapy. She was commenced on desmopressin,
with subsequent clinical and biochemical improvement,
alongside multidisciplinary management.
Conclusion
In patients with type 2 diabetes mellitus, persistent polyuria
may obscure an underlying water balance disorder. This
case highlights the importance of considering alternative
causes of polyuria and a systematic endocrine approach to
ensure accurate diagnosis and appropriate management.
Diabetes Mellitus, Type 2
;
Hyperglycemic Hyperosmolar Nonketotic Coma
;
Diabetes Insipidus


Result Analysis
Print
Save
E-mail